Huntington National Bank’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-37
| Closed | -$530 | – | 4166 |
|
|
2025
Q3 | $530 | Buy |
+37
| New | +$507 | ﹤0.01% | 2387 |
|
|
2025
Q2 | – | Sell |
-1,194
| Closed | -$26.3K | – | 4188 |
|
|
2025
Q1 | $26.3K | Sell |
1,194
-230
| -16% | -$5.41K | ﹤0.01% | 1433 |
|
|
2024
Q4 | $32.3K | Buy |
1,424
+240
| +20% | +$5.24K | ﹤0.01% | 1381 |
|
|
2024
Q3 | $21.5K | Sell |
1,184
-591
| -33% | -$13.7K | ﹤0.01% | 1486 |
|
|
2024
Q2 | $51.7K | Sell |
1,775
-1,488
| -46% | -$44.1K | ﹤0.01% | 1103 |
|
|
2024
Q1 | $116K | Buy |
3,263
+311
| +11% | +$12.4K | ﹤0.01% | 850 |
|
|
2023
Q4 | $129K | Sell |
2,952
-197
| -6% | -$7.75K | ﹤0.01% | 777 |
|
|
2023
Q3 | $120K | Sell |
3,149
-246
| -7% | -$10.3K | ﹤0.01% | 771 |
|
|
2023
Q2 | $140K | Buy |
3,395
+435
| +15% | +$20.9K | ﹤0.01% | 749 |
|
|
2023
Q1 | $170K | Buy |
2,960
+164
| +6% | +$9.24K | ﹤0.01% | 665 |
|
|
2022
Q4 | $157K | Sell |
2,796
-30
| -1% | -$1.53K | ﹤0.01% | 674 |
|
|
2022
Q3 | $120K | Buy |
2,826
+581
| +26% | +$29.8K | ﹤0.01% | 716 |
|
|
2022
Q2 | $121K | Buy |
2,245
+289
| +15% | +$17.4K | ﹤0.01% | 741 |
|
|
2022
Q1 | $126K | Sell |
1,956
-3
| -0.2% | -$198 | ﹤0.01% | 769 |
|
|
2021
Q4 | $131K | Buy |
1,959
+46
| +2% | +$3.11K | ﹤0.01% | 769 |
|
|
2021
Q3 | $131K | Buy |
1,913
+120
| +7% | +$8.48K | ﹤0.01% | 694 |
|
|
2021
Q2 | $122K | Buy |
1,793
+417
| +30% | +$29.5K | ﹤0.01% | 700 |
|
|
2021
Q1 | $95K | Hold |
1,376
| – | – | ﹤0.01% | 670 |
|
|
2020
Q4 | $89K | Hold |
1,376
| – | – | ﹤0.01% | 660 |
|
|
2020
Q3 | $65K | Hold |
1,376
| – | – | ﹤0.01% | 716 |
|
|
2020
Q2 | $65K | Sell |
1,376
-53
| -4% | -$2.6K | ﹤0.01% | 729 |
|
|
2020
Q1 | $64K | Sell |
1,429
-4
| -0.3% | -$210 | ﹤0.01% | 711 |
|
|
2019
Q4 | $84K | Sell |
1,433
-239
| -14% | -$14.2K | ﹤0.01% | 756 |
|
|
2019
Q3 | $100K | Hold |
1,672
| – | – | ﹤0.01% | 658 |
|
|
2019
Q2 | $93K | Sell |
1,672
-24
| -1% | -$1.24K | ﹤0.01% | 684 |
|
|
2019
Q1 | $95K | Sell |
1,696
-12
| -0.7% | -$611 | ﹤0.01% | 704 |
|
|
2018
Q4 | $77K | Buy |
1,708
+149
| +10% | +$8.18K | ﹤0.01% | 730 |
|
|
2018
Q3 | $103K | Buy |
1,559
+92
| +6% | +$5.72K | ﹤0.01% | 715 |
|
|
2018
Q2 | $94K | Sell |
1,467
-660
| -31% | -$40.9K | ﹤0.01% | 750 |
|
|
2018
Q1 | $118K | Sell |
2,127
-2
| -0.1% | -$105 | ﹤0.01% | 706 |
|
|
2017
Q4 | $102K | Hold |
2,129
| – | – | ﹤0.01% | 772 |
|
|
2017
Q3 | $107K | Hold |
2,129
| – | – | ﹤0.01% | 746 |
|
|
2017
Q2 | $116K | Hold |
2,129
| – | – | ﹤0.01% | 703 |
|
|
2017
Q1 | $90K | Buy |
2,129
+265
| +14% | +$11.3K | ﹤0.01% | 768 |
|
|
2016
Q4 | $80K | Sell |
1,864
-702
| -27% | -$28.5K | ﹤0.01% | 803 |
|
|
2016
Q3 | $106K | Buy |
+2,566
| New | +$108K | ﹤0.01% | 762 |
|
|
2016
Q2 | – | Sell |
-180
| Closed | -$6K | – | 1580 |
|
|
2016
Q1 | $6K | Buy |
+180
| New | +$5.61K | ﹤0.01% | 1546 |
|
|
2015
Q3 | – | Sell |
-191
| Closed | -$5K | – | 1754 |
|
|
2015
Q2 | $5K | Sell |
191
-29
| -13% | -$773 | ﹤0.01% | 1603 |
|
|
2015
Q1 | $6K | Buy |
220
+122
| +124% | +$2.88K | ﹤0.01% | 1556 |
|
|
2014
Q4 | $2K | Buy |
+98
| New | +$1.99K | ﹤0.01% | 1643 |
|
Other funds holding IART
RCMNY
PCMI
Huntington National Bank's IART Position: Q4 2025 in Review
Huntington National Bank sold out of Integra LifeSciences (IART) in Q4 2025, closing a stake of 37 shares — an estimated $530 sold.
Huntington National Bank first reported a position in IART in Q4 2014 and held it in 40 quarters. The position peaked at $170K in Q1 2023. 204 funds tracked by Wall St. Rank hold IART as of Q4 2025.
- Huntington National Bank reported no remaining Integra LifeSciences position as of Q4 2025 after selling out during the quarter.
- Huntington National Bank sold 37 Integra LifeSciences shares in Q4 2025, an estimated $530.
- Huntington National Bank first reported a position in Integra LifeSciences in Q4 2014 and held it in 40 quarters.
- Huntington National Bank's Integra LifeSciences position peaked at $170K in Q1 2023.
- 204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.
Based on Huntington National Bank's 13F filing for Q4 2025, filed 9 Feb 2026.